Fiona Yull

Last active: 3/21/2018

  1. Selective cell ablation in transgenic mice expression E. coli nitroreductase. Clark AJ, Iwobi M, Cui W, Crompton M, Harold G, Hobbs S, Kamalati T, Knox R, Neil C, Yull F, Gusterson B (1997) Gene Ther 4(2): 101-10
    › Primary publication · 9081700 (PubMed)
  2. Mammalian cDNA and prokaryotic reporter sequences silence adjacent transgenes in transgenic mice. Clark AJ, Harold G, Yull FE (1997) Nucleic Acids Res 25(5): 1009-14
    › Primary publication · 9023112 (PubMed) · PMC146529 (PubMed Central)
  3. Restricted tissue-specific but correct developmental expression mediated by a short human alpha 1AT promoter fragment in transgenic mice. Yull FE, Wallace RM, Clark AJ (1995) Transgenic Res 4(1): 70-4
    › Primary publication · 7881464 (PubMed)
  4. Fixing human factor IX (fIX): correction of a cryptic RNA splice enables the production of biologically active fIX in the mammary gland of transgenic mice. Yull F, Harold G, Wallace R, Cowper A, Percy J, Cottingham I, Clark AJ (1995) Proc Natl Acad Sci U S A 92(24): 10899-903
    › Primary publication · 7479906 (PubMed) · PMC40538 (PubMed Central)
  5. Chromosomal position effects and the modulation of transgene expression. Clark AJ, Bissinger P, Bullock DW, Damak S, Wallace R, Whitelaw CB, Yull F (1994) Reprod Fertil Dev 6(5): 589-98
    › Primary publication · 7569038 (PubMed)
  6. Reconstruction of the yeast 2 micron plasmid partitioning mechanism. Dobson MJ, Yull FE, Molina M, Kingsman SM, Kingsman AJ (1988) Nucleic Acids Res 16(14B): 7103-17
    › Primary publication · 3043377 (PubMed) · PMC338354 (PubMed Central)